Ruben L. De Groen

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models.

Alternative oncogenic drivers and sensitivity to BTK inhibition in CRISPR/Cas gene-edited human DLBCL cell models.

Journal: Blood neoplasia

Published: February 17, 2026

Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma.

Non-inferior outcome of abbreviated R-CHOP in patients with stage I primary testicular lymphoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 26, 2025

IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center Lymphoma.

IgM Immunohistochemical Expression is a Potential Risk Factor for Extracutaneous Dissemination in Patients With Primary Cutaneous Follicle Center Lymphoma.

Journal: The American journal of surgical pathology

Published: June 13, 2025

Therapy for MYD88 L265P DLBCL.

Therapy for MYD88 L265P DLBCL.

Journal: Blood

Published: March 06, 2025

MATRix and HD-MTX/IFO/DEP treatment and autologous stem cell transplantation in secondary central nervous system lymphoma: a Dutch retrospective analysis.

MATRix and HD-MTX/IFO/DEP treatment and autologous stem cell transplantation in secondary central nervous system lymphoma: a Dutch retrospective analysis.

Journal: Haematologica

Published: January 30, 2025

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

Journal: Haematologica

Published: December 06, 2024

Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.

Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment.

Journal: Blood cancer journal

Published: November 01, 2024

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 22, 2024

CaClust: linking genotype to transcriptional heterogeneity of follicular lymphoma using BCR and exomic variants.

CaClust: linking genotype to transcriptional heterogeneity of follicular lymphoma using BCR and exomic variants.

Journal: Genome biology

Published: April 17, 2024

The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.

The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.

Journal: International journal of molecular sciences

Published: January 29, 2024

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.

Journal: Blood advances

Published: August 24, 2023

Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.

Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomas.

Journal: Virchows Archiv : an international journal of pathology

Published: July 03, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026